Skip to content
Broadly Epi

Broadly Epi

Epidemiology, Broadly Speaking

  • Home
  • Rent-A-Scientist
  • Software
    • Broadly Epi MMWR Archive Database
    • HSE Specialty Care Finder
  • Data Rebellion
    • Social Vulnerability Index Archive and Data Mart
  • Care Resources
    • LGBTQIA+ Health Resources
    • Health Care Affordability Resources
    • List of Resources for People Who Use Drugs
  • Blog
    • Epi Explained: Simplified Epidemiology Concepts
    • MMWR Booster: Simplified Research
    • Python Tutorials
    • R Tutorials
    • Emerging Study
    • Community Experts
  • Contact Us

Tag: SCD

Social Vulnerability and Sickle Cell Disease Mortality: A Call for Equitable Healthcare

Posted on October 2, 2024 by Cody Micah Carmichael MPH, CPH

Social Vulnerability and Sickle Cell Disease Mortality: A Call for Equitable Healthcare Key Takeaways Counties with higher social vulnerability had significantly higher sickle cell disease (SCD) mortality rates, revealing critical

Read More
Emerging Study Health Equity, SCD, SVI Leave a comment

Search

Categories

Recent Posts

  • Community Experts Issue 3: Rowan Odom’s Story – Living with an Undiagnosed Chronic Illness February 1, 2025
  • MMWR Booster for: Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021 / February 25, 2022 / 71(8);290–292 January 11, 2025
  • MMWR Booster for: Screening Programs for SARS-CoV-2 Infections on a University Campus — Austin, Texas, September 30–November 30, 2020 / September 3, 2021 / 70(35);1201–1205 January 10, 2025
  • MMWR Booster for: Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 — United States, December 14–19, 2021 / February 25, 2022 / 71(8);299–305 January 10, 2025
  • MMWR Booster for: Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break — Chicago, Illinois, March–May 2021 / September 3, 2021 / 70(35);1195–1200 January 9, 2025
  • MMWR Booster for: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 / March 4, 2022 / 71(9);352–358 January 9, 2025
  • MMWR Booster for: Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 / February 25, 2022 / 71(8);285–289 January 8, 2025
  • MMWR Booster for: Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-Associated Illnesses — United States, 2017–2019 / September 3, 2021 / 70(35);1191–1194 January 8, 2025
  • MMWR Booster for: Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022 / March 4, 2022 / 71(9);347–351 January 7, 2025
  • MMWR Booster for: National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020 / September 3, 2021 / 70(35);1183–1190 January 7, 2025
  • Github
  • BlueSky
  • Threads
  • LinkedIn